Top compounds associated with response to TRO


Feature Type Standardized
Nominal ANOVA
mRNA FK866 GDSC1000 pan-cancer AAC 0.16 4e-06
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.16 4e-06
mRNA ML239 CTRPv2 pan-cancer AAC 0.18 4e-06
mRNA pac-1 CTRPv2 pan-cancer AAC 0.18 5e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 5e-06
mRNA manumycin A CTRPv2 pan-cancer AAC 0.16 6e-06
mRNA SMER-3 CTRPv2 pan-cancer AAC 0.19 6e-06
mRNA FQI-2 CTRPv2 pan-cancer AAC 0.17 6e-06
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 7e-06
mRNA epigallocatechin-3-monogallate CTRPv2 pan-cancer AAC 0.18 9e-06
Download CSV